Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

wael pharmacy - hepatitis a virus vaccine - injection - 0.5

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - hepatitis a virus inactivated - emulsion for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmabroker sales ltd - hepatitis a vaccine 500 ria u (at least per 0.5ml dose) - suspension for injection - 500 ria u - active: hepatitis a vaccine 500 ria u (at least per 0.5ml dose) excipient: formaldehyde influenza virus a/singapore/6/86 phospholipids sodium chloride as solution, up to 0.5ml

Ireland - English - HPRA (Health Products Regulatory Authority)

crucell italy s.r.l. - hepatitis a virus (strain rg-sb) - suspension for injection

Ireland - English - HPRA (Health Products Regulatory Authority)

crucell italy s.r.l. - hepatitis a virus (strain rg-sb) - suspension for injection - %v/v

Israel - English - Ministry of Health

droreth ltd - hepatitis a antigen 24 iu / 0.5 ml - solution for injection - hepatitis a, inactivated, whole virus - active immunization against hepatitis a for adults and children age 1 year and above.

Canada - English - Health Canada

berna biotech ltd - hepatitis a vaccine, inactivated - liquid - 500unit - hepatitis a vaccine, inactivated 500unit - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

masta ltd - hepatitis a virus inactivated - suspension for injection

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - paroxetine hydrochloride hemihydrate (unii: x2els050d8) (paroxetine - unii:41vrh5220h) - paxil is indicated for the treatment of major depressive disorder. the efficacy of paxil in the treatment of a major depressive episode was established in 6‑week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm‑iii category of major depressive disorder (see clinical pharmacology: clinical trials). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the effects of paxil in hospitalized depressed patients have not been adequately studied. the efficacy of paxil in maintaining a